AI Science Tracker
EN

MediaTek Inc.

1 discovery from 2021

Discoveries

Neuroimage Biomarker Identification of the Conversion of Mild Cognitive Impairment to Alzheimer's Disease.

Source check: Source checked. Not independent scientific confirmation.

Finding: Machine-learning analysis of MRI volume, surface-area and related features predicted conversion from mild cognitive impairment to Alzheimer’s disease, evaluated against longitudinal outcomes. The paper appeared in Frontiers in Neuroscience. Organization is unavailable in the deposited bibliographic metadata.

Technology: Random-forest feature selection and multilayer perceptron

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Random-forest feature selection and a multilayer perceptron classified MCI-to-Alzheimer conversion using hippocampal morphology measures.
Test and result
Machine-learning analysis of MRI volume, surface-area and related features predicted conversion from mild cognitive impairment to Alzheimer’s disease, evaluated against longitudinal outcomes.
Limitation / still unknown
The reviewed study does not establish validation or benefit beyond its reported evaluation.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://doi.org/10.3389/fnins.2021.584641

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.